Cargando...
Sucrosomial(®) Iron: A New Generation Iron for Improving Oral Supplementation
Iron deficiency (ID) is usually treated with oral iron salts, but up to 50% of patients complain of gastrointestinal side effects, leading to reduced compliance with treatment. Intravenous (IV) iron formulations are increasingly safe, but there is still a risk of infusion, hypersensitivity reactions...
Gardado en:
| Publicado en: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6316120/ https://ncbi.nlm.nih.gov/pubmed/30287781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11040097 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|